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1. Introduction 
The main metabolites of polycyclic hydrocarbons 
are hydroxylated derivatives [ 1] . These could theore- 
tically arise from epoxide intermediates [2] formed 
by the NADPHdependent microsomal mixed function 
oxidase. K-region epoxides of polycyclic hydrocarbons 
that have been prepared synthetically [3] have been 
shown to be alkylating agents that react covalently 
with nucleic acids [4] and with the constituents of 
cells in culture [S] . These K-region epoxides are also 
mutagenic to T, bacteriophage [6] , to bacteria [7] , 
to Drosophila [8] and to Chinese hamster cells [9] 
and are active in producing malignant transformation 
of cells in culture [lo]. Consequently, it seemed im- 
portant to establish that epoxides are in fact involved 
in the metabolism of polycyclic hydrocarbons. In the 
experiments described here, direct evidence has been 
obtained that epoxides are formed as microsomal 
metabolites of phenanthrene, benz[a] anthracene and 
dibenz[a,hh] anthracene. 
2. Materials and methods 
Glucose-6-phosphate dehydrogenase and cofactors 
were purchased from Boehringer (Mannheim) and 
3H-labelled hydrocarbons (specific activities: phen- 
anthrene 470 mCi/mmole, benz[a] anthrecene 450 
mCi/mmole, dibenz[a,h] anthracene 400 mCi/mmole) 
from the Radiochemical Centre, Amersham, Bucks. 
Washed rat liver microsomes were prepared from 
animals pretreated with 3-methylcholanthrene [I] . 
Incubation mixtures consisting of microsomes (s 10 g 
liver) resuspended in pyrophosphate buffer (0.1 M, 
76 
pH 8 .O, 80 ml) containing glucose&phosphate (1 
mmole), glucose-6-phosphate dehydrogenase (96 units), 
NADPH (48 bmole), nicotinamide (2 mmole), MgCl, 
(1 mmole) and styrene oxide (8.3 pmole) were pre- 
incubated for 10 min at 30”. ‘H-Labelled hydro- 
carbon (400 pg) was added in DMSO (0.2 ml) and 
after incubation for 3 min at 30”, the mixture was 
extracted with ether (I vol.). The appropriate un- 
labelled K-region epoxide (3 mg) was added to the 
ether extract which was then dried, concentrated and 
chromatographed on an alumina column as described 
in the legend to fig. 1. Fractions containing the eluted 
epoxide peaks were pooled, concentrated and used to 
confirm the presence of radioactively labelled epoxide. 
3. Results 
Figs. 1 and 2 show the elution profiles obtained 
with extracts from microsomal incubations of 3H- 
phenanthrene and 3H-benz [a] anthracene. In each 
case, a radioactive peak was eluted, between those of 
the unchanged hydrocarbon and the dihydrodiol, that 
was coincident with the UV absorbent peak of the 
unlabelled carrier epoxide. Table 1 shows the crystal- 
lisation to constant specific activity of these radio- 
active epoxides using additional unlabelled samples of 
phenanthrene 9 ,lO oxide and benz[a] anthracene 5,6 
oxide as carriers. 
Fig. 3 shows the results obtained when radioactive 
epoxide, obtained from a 3H-dibenz[ab] anthracene 
incubation, was treated with acid to rearrang the 
epoxide to the corresponding phenolic compound. 
The products, when examined by thin layer chroma- 
tography, included a radioactive spot with an Rf 
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Fig. 1. Column chromatography of 3H-phenanthrene metabolites. The concentrated ether extract from a rat liver microsomal in- 
cubation (see text) was applied to a column (1.3 X 4 cm) of activated alumina (100-200 mesh, Type H) and eluted with solvent. 
lOOdrop fractions were collected and radioactivity and UV absorbance measured. 
Table 1 
Recrystallisation of phenanthrene 9,lO-oxide and benz[a] anthracene 5,6-oxide containing radioactive epoxide formed from the 
corresponding 3H-hydrocarbon. 
Phenanthrene 9,lGoxide 
Crystallisation Yield (mg) 
1 42.8 
2 36.2 
3 29.3 
4 23.8 
dpm/mg (X 104) 
6.08 
5.10 
5.22 
4.99 
Benz[ a] anthracene 5,6-oxide 
Crystallisation Yield (mg) 
1 39.6 
2 33.2 
3 26.4 
4 17.3 
dpm/mg (X 1 0W4) 
8.75 
6.55 
8.45 
7.70 
Samples (SO mg) of unlabelled phenanthrene 9,10-oxide or benz[ a] anthracene 5,6-oxide were added to pooled fractions contain- 
ing the radioactive epoxide peaks obtained by alumina column chromatography of ether-extracts of 3H-phenanthrene or 3H- 
benz[a] anthracene incubations. The solutions were evaporated to dryness and the epoxide repeatedly crystallised from cyclo- 
hexane. 
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Fig. 2. Column chromatography of 3H-benz[ a] anthracene metabolites. (For details, see legend to fig. 1.) 
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Fig. 3. Acid-catalysed rearrangement of radioactive epoxide 
from a 3H-dibenz[ a,h] anthracene incubation. Fractions con- 
taining tbe carrier epoxide peak from an alumina column were 
pooled and evaporated and the residue redissolved in methanol. 
The solution was acidified and the rearrangement products 
examined as previously described [ 11) using thin-layer chro 
matography on silica gel G developed with benzene:ethanol, 
similar to that of authentic Shydroxydibenz [ah] an- 
thracene [l] . 
When incubated with microsomal epoxide hydrase 
[ 121, radioactive epoxide, formed metabolically from 
3H-phenanthrene, was converted into products that in- 
cluded one with the thin layer chromatographic char- 
acteristics of trans-9,10-dihydro-9,lOdihydroxyphen 
anthrene (fig. 4) [ 131. In addition, when radioactive 
epoxide formed metabolically from 3H-benz[a] an- 
thracene, was refluxed with glutathione at alkaline pH, 
a radioactive product was formed that possessed the 
paper chromatographic properties of the acid-labile 
glutathione conjugate formed from authentic benz[a] - 
anthracene 5,6-oxide [ 1 l] (fig. 5). 
4. Discussion 
These investigations demonstrate that epoxides are 
formed when the polycyclic hydrocarbons phenan- 
threne, benz[a] anthracene or dibenz[ah] anthracene 
are metabolished in vitro by the NADPH-dependent 
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Fig. 4. Enzymecatalysed conversion of radioactive phenan- 
threne epoxide to the corresponding dihydrodiol. Fractions 
containing the carrier epoxide peak, obtained by column 
chromatography of an ether extract from a 3H-phena.nthrene 
incubation, were pooled and evaporated to dryness. The 
residue was redissolved in acetone (0.2 ml) and incubated for 
1 hr at 37” with rat liver microsomes (= 10 g liver) resuspended 
in Tris buffer (pH 7.4, 0.1 M, 50 ml). The ether-soluble pro- 
ducts were examined as previously described [ 13 ] , using thin 
layer chromatography on silica gel G developed with benzene: 
ethanol, 19:l. 
microsomal mixed function oxidase of rat liver and 
that these radioactive epoxides can be converted, 
under appropriate conditions, into the corresponding 
dihydrodiol, phenol or glutathione derivatives (figs. 
3-5). 
The specific activities of the radioactive epoxides 
isolated from microsomal incubations of phenanthrene 
or benz[a] anthracene did not fall on repeated 
recrystallisation with the respective carrier K-region 
epoxides. This indicates that with these two hydro- 
carbons, the epoxides formed are most probably the 
K-region derivatives. The site of oxidation of 
dibenz[a,h] anthracene in these experiments has not 
been determined to date; the formation of uncharac- 
terised epoxide derivatives of this hydrocarbon in 
microsomal incubation mixtures has also been 
described by Selkirk et al. [ 141. 
The evidence that has accumulated from work on 
benzene [ 121, on naphthalene [ 151 and on the three 
polycyclic hydrocarbons examined here, clearly shows 
that the initial step in the microsomal oxidation of 
- 
Fig. 5. Formation of acid-labile glutathione conjugate of radio- 
active benz[a] anthracene poxide. Fractions containing the 
carrier epoxide peak, obtained by column chromatography of 
an etherextract from a 3H-benz[a] anthracene incubation 
were pooled and evaporated to dryness. The residue was re- 
dissolved in acetone (5 ml) and refluxed for 18 hr with an 
aqueous olution (5 ml) containing glutathione (2.5 mg) and 
sodium bicarbonate (5 mg). The products were examined, as 
previously described [ 111, using paper chromatography on 
Whatman 3 MM developed with butan-1-ol:propan-l+A:aq. 
2 M NH3 (2:l:l by vol.). 
aromatic double bonds is the formation of an epoxide. 
This conclusion supports the working hypothesis that 
polycyclic hydrocarbon carcinogenesis results from 
somatic mutations produced by epoxide intermediates 
[4-IO]. However, it does not explain why, in a range 
of hydrocarbons metabolised by similar pathways, 
some are potent carcinogens whilst others are not; 
this problem is currently under investigation. 
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